KAINAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kainair, and when can generic versions of Kainair launch?
Kainair is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in KAINAIR is proparacaine hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kainair
A generic version of KAINAIR was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KAINAIR?
- What are the global sales for KAINAIR?
- What is Average Wholesale Price for KAINAIR?
Summary for KAINAIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Patent Applications: | 3,994 |
| DailyMed Link: | KAINAIR at DailyMed |
US Patents and Regulatory Information for KAINAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | KAINAIR | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 088087-001 | Jun 7, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
